There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.
Overall, though, the meta-analysis identified a reduction in ischemia—but not in hard outcomes—with early treatment.
It is important to not ignore a mini stroke as it can be a warning sign of a brain stroke. According to Mayo Clinic, about 1 ...
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
MicroTransponder announced today that it raised $65 million in a Series F financing round to support its Vivistim system.
3d
Medical Device Network on MSNMicroTransponder receives $65m to advance stroke care with VivistimMicroTransponder has received $65m in Series F funds to enhance its stroke care offerings with the Vivistim Paired VNS System ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
The autopsy report from the NC Office of the Chief Medical Examiner concluded that Stuart C. Mast, 48, of Fleetwood, died ...
Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...
Kicked off of Medicaid, Florida children with medically complex needs are offered a state insurance program designed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results